Download PDF
1 / Pages

Other users also viewed these articles

Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study) Alberto Martínez-Castelao; José Luis Górriz Teruel; Luis D¿Marco; Enrique Garrigós; Gema Fernández-Fresnedo; Eugenia Espinel Garuz; Secundino Cigarrán Guldris; Jesús Arteaga Coloma; Nicolas Roberto Robles Pérez-Monteoliva; José Rafael Esteban de la Rosa; Luis Javier Nieto Iglesias; Alberto Ortiz Arduán; Juan Francisco Navarro-González;
10.1016/j.nefroe.2024.10.002
Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain Roberto Alcázar-Arroyo; María G Crespo-Leiro; Jordi Bover; Juan Oliva; Miren Sequera-Mutiozabal; Simona Gradari; Anisia Martínez-López; Blanca López-Chicheri; Neus Vidal-Vilar; Susana Aceituno; Marta Cobo;
10.1016/j.nefroe.2024.10.001
Nomenclature in Palliative and Kidney Supportive Care: Not Just at the End-of-Life Lina Nitola-Mendoza; Miguel Sánchez-Cárdenas; Néstor Rodriguez-Chitiva; José María Mora Gutiérrez; Rosely Rodriguez-Pena; Gregorio Romero-González; Monserrat Bleda Pérez; Paula Cuenca Casbas; Agnès Calsina-Berna; Margarita Álvaro-Pardo; Virginia Granados Casas; Paula Garrido Ballart; Patricia Beroiz Groh; Jordi Bover; Ramón Miralles Basseda; Juan Pablo Leiva-Santos; Alberto Alonso-Babarro; Joaquim Julià-Torras;
Nefrologia (English Version). 2024;44:475-85